| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1532 |
| Trial ID | NCT02445248 |
| Disease | Diffuse Large B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | Kymriah|Tisagenlecleucel |
| Generation | 2nd |
| Phase | Phase2 |
| Recruitment status | Completed |
| Title | Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients |
| Year | 2015 |
| Country | United States |
| Company sponsor | Novartis Pharmaceuticals |
| Other ID(s) | CCTL019C2201|2014-003060-20 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||||
|
|||||||||||||